- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Placebo to BI 456906
Total 1481 results
-
Boehringer IngelheimWithdrawn
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimRecruiting
-
Boehringer IngelheimActive, not recruiting
-
Boehringer IngelheimCompletedDiabetic NephropathiesSpain, Australia, United States, Canada, China, Japan, Malaysia, United Kingdom, Mexico, Portugal, Denmark, Hong Kong, Poland, New Zealand, Argentina, Netherlands
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimNot yet recruitingIdiopathic Pulmonary Fibrosis
-
Boehringer IngelheimRecruitingBronchiectasisUnited States, Korea, Republic of, Belgium, Germany, Spain, Italy, Netherlands, Denmark, Australia, Mexico, Israel, Bulgaria, Hungary, Turkey, Czechia, France, Latvia, Poland, United Kingdom, Japan, Canada, Portugal
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany, Netherlands
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedPsoriasisUnited States, Canada, Germany
-
Boehringer IngelheimNot yet recruitingIdiopathic Pulmonary Fibrosis | Progressive Pulmonary Fibrosis
-
Boehringer IngelheimRecruitingKidney Disease, ChronicUnited States, Belgium, Australia, Spain, Germany, France, Italy, New Zealand, United Kingdom, China
-
Boehringer IngelheimActive, not recruiting
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedBronchiectasisSpain, United States, Denmark, Belgium, Korea, Republic of, Canada, Italy, Japan, Bulgaria, Australia, Latvia, Netherlands, United Kingdom, Germany, Israel, France, Hungary, Mexico, Greece, Poland, Turkey, Czechia, Portugal
-
Boehringer IngelheimActive, not recruiting
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedNon-cystic Fibrosis BronchiectasisUnited Kingdom, Germany
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedSafety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular EdemaMacular EdemaSpain, United Kingdom, Germany, Portugal, France, Belgium, Hungary, Greece
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedLupus NephritisSpain, United Kingdom, United States, Canada, Thailand, Germany, Italy, Japan, Serbia, Australia, Korea, Republic of, Mexico, Malaysia, Philippines, Poland, Portugal, Greece, Hong Kong, Czechia, France
-
Boehringer IngelheimCompletedEffectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental PainPain, PostoperativeItaly
-
Boehringer IngelheimRecruitingNetherton SyndromeBelgium, United Kingdom, Australia, Germany, China, Malaysia, United States, Japan, France, Israel, Bulgaria, Italy, Finland, Switzerland, Netherlands, Portugal
-
Boehringer IngelheimRecruitingPsoriasisBulgaria, Romania, Moldova, Republic of, Georgia
-
Boehringer IngelheimCompletedPost-Traumatic Stress DisorderUnited States, Germany, Sweden, Finland, Israel, Poland, Mexico, Croatia
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedBorderline Personality DisorderSpain, Germany, Sweden, United States, Mexico, Argentina, France, Poland, Australia, Belgium, Bulgaria, Czechia, Denmark, Italy, Japan
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompletedHealthyKorea, Republic of
-
Boehringer IngelheimTerminated
-
Boehringer IngelheimTerminatedCOVID-19Spain, United States, Mexico, Brazil, Chile, Puerto Rico
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimWithdrawnLupus Erythematosus, Systemic
-
Boehringer IngelheimWithdrawn